BioMark Diagnostics Inc.
BUX
CNSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.07M | -1.22M | -1.18M | -1.24M | -1.39M |
| Total Depreciation and Amortization | 275.70K | 394.70K | 335.30K | 315.10K | 284.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 72.80K | 79.80K | 76.00K | 155.30K | 311.10K |
| Change in Net Operating Assets | -69.10K | -273.30K | -234.80K | 11.90K | 13.40K |
| Cash from Operations | -787.00K | -1.02M | -1.01M | -752.80K | -780.70K |
| Capital Expenditure | -2.00K | -451.30K | -8.40K | -2.10K | -2.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -281.40K | -573.80K | -592.20K | -1.36M | -- |
| Cash from Investing | -283.30K | -1.03M | -600.60K | -1.36M | -2.50K |
| Total Debt Issued | 357.20K | 1.00M | 378.20K | 378.20K | 378.20K |
| Total Debt Repaid | -757.60K | -663.40K | -632.50K | -601.40K | -567.80K |
| Issuance of Common Stock | 22.50K | 2.93M | 3.19M | 3.24M | 3.61M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -23.40K | -- | -- | -- |
| Cash from Financing | -273.40K | 2.27M | 2.04M | 2.10M | 2.40M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.34M | 229.20K | 435.40K | -12.80K | 1.62M |